Reviewed,
UniProtKB/Swiss-Prot P05129 (KPCG_HUMAN)
Last modified
September 2, 2008.
Version 103.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Protein kinase C gamma type Short name=PKC-gamma EC=2.7.11.13 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 697 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | This is a calcium-activated, phospholipid-dependent, serine- and threonine-specific enzyme. PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters. |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Cofactor | Binds 3 calcium ions per subunit. The ions are bound to the C2 domain By similarity. |
| Subunit structure | Interacts with CDCP1. |
| Involvement in disease | Defects in PRKCG are the cause of spinocerebellar ataxia type 14 (SCA14) [MIM:605361]. Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA14 is an autosomal dominant cerebellar ataxia (ADCA). |
| Sequence similarities | Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily. Contains 1 AGC-kinase C-terminal domain. Contains 1 C2 domain. Contains 2 phorbol-ester/DAG-type zinc fingers. Contains 1 protein kinase domain. |
Ontologies
Keywords | |
|---|---|
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation Neurodegeneration Spinocerebellar ataxia |
| Domain | Phorbol-ester binding Repeat Zinc-finger |
| Ligand | ATP-binding Calcium Metal-binding Nucleotide-binding Zinc |
| Molecular function | Kinase Serine/threonine-protein kinase Transferase |
| PTM | Phosphoprotein |
| Technical term | 3D-structure |
Gene Ontology (GO) | |
| Biological process | negative regulation of protein catabolic process Inferred from direct assay. Source: HGNC negative regulation of protein ubiquitinationInferred from direct assay. Source: HGNC positive regulation of mismatch repairInferred from direct assay. Source: HGNC protein amino acid phosphorylation Ref.3Traceable author statement. Source: ProtInc |
| Molecular function | protein kinase C activity Ref.3 Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | |||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 697 | 697 | Protein kinase C gamma type | ||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||
| Domain | 170 – 260 | 91 | C2 | ||||||||||||||||||||||||||
| Domain | 351 – 614 | 264 | Protein kinase | ||||||||||||||||||||||||||
| Domain | 615 – 685 | 71 | AGC-kinase C-terminal | ||||||||||||||||||||||||||
| Zinc finger | 35 – 85 | 51 | Phorbol-ester/DAG-type 1 | ||||||||||||||||||||||||||
| Zinc finger | 100 – 150 | 51 | Phorbol-ester/DAG-type 2 | ||||||||||||||||||||||||||
| Nucleotide binding | 357 – 365 | 9 | ATP By similarity | ||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||
| Active site | 480 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||
| Metal binding | 186 | 1 | Calcium 1; via carbonyl oxygen By similarity | ||||||||||||||||||||||||||
| Metal binding | 187 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||
| Metal binding | 187 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||
| Metal binding | 193 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||
| Metal binding | 246 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||
| Metal binding | 246 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||
| Metal binding | 247 | 1 | Calcium 2; via carbonyl oxygen By similarity | ||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 2 By similarity | ||||||||||||||||||||||||||
| Metal binding | 248 | 1 | Calcium 3 By similarity | ||||||||||||||||||||||||||
| Metal binding | 251 | 1 | Calcium 3 By similarity | ||||||||||||||||||||||||||
| Metal binding | 252 | 1 | Calcium 3; via carbonyl oxygen By similarity | ||||||||||||||||||||||||||
| Metal binding | 254 | 1 | Calcium 1 By similarity | ||||||||||||||||||||||||||
| Metal binding | 254 | 1 | Calcium 3 By similarity | ||||||||||||||||||||||||||
| Binding site | 380 | 1 | ATP By similarity | ||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||
| Modified residue | 195 | 1 | Phosphotyrosine | ||||||||||||||||||||||||||
| Modified residue | 312 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||
| Modified residue | 322 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||
| Modified residue | 330 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||
| Modified residue | 514 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||
| Modified residue | 518 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||
| Modified residue | 648 | 1 | Phosphothreonine; by autocatalysis Potential | ||||||||||||||||||||||||||
| Modified residue | 655 | 1 | Phosphothreonine; by autocatalysis Potential | ||||||||||||||||||||||||||
| Modified residue | 687 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||
| Natural variant | 101 | 1 | H → Y in SCA14. | ||||||||||||||||||||||||||
| Natural variant | 119 | 1 | S → P in SCA14. | ||||||||||||||||||||||||||
| Natural variant | 128 | 1 | G → D in SCA14. | ||||||||||||||||||||||||||
| Natural variant | 141 | 1 | R → C | ||||||||||||||||||||||||||
| Natural variant | 415 | 1 | H → Q | ||||||||||||||||||||||||||
| Natural variant | 523 | 1 | A → D | ||||||||||||||||||||||||||
| Natural variant | 659 | 1 | R → S | ||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||
| Beta strand | 160 – 169 | 10 | |||||||||||||||||||||||||||
| Beta strand | 172 – 182 | 11 | |||||||||||||||||||||||||||
| Beta strand | 194 – 201 | 8 | |||||||||||||||||||||||||||
| Beta strand | 222 – 230 | 9 | |||||||||||||||||||||||||||
| Helix | 233 – 237 | 5 | |||||||||||||||||||||||||||
| Beta strand | 239 – 246 | 8 | |||||||||||||||||||||||||||
| Beta strand | 249 – 251 | 3 | |||||||||||||||||||||||||||
| Beta strand | 254 – 262 | 9 | |||||||||||||||||||||||||||
| Helix | 263 – 268 | 6 | |||||||||||||||||||||||||||
| Beta strand | 271 – 276 | 6 | |||||||||||||||||||||||||||
| Helix | 280 – 283 | 4 | |||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Cui W.C., Yu L., Chu Y.Y., Wang J., Zheng L.H., Zhou G.J., Zhao S.Y. Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [3] | "Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways." Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E., Waterfield M.D., Francke U., Ullrich A. Science 233:859-866(1986) [PubMed: 3755548] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-318. Tissue: Brain. |
| [4] | "Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes." Kochs G., Hummel R., Meyer D., Hug H., Marme D., Sarre T.F. Eur. J. Biochem. 216:597-606(1993) [PubMed: 8375396] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 162-697. Tissue: Hippocampus. |
| [5] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, MASS SPECTROMETRY. |
| [6] | "Segregation of a PRKCG mutation in two RP11 families." Al-Maghtheh M., Vithana E.N., Inglehearn C.F., Moore T., Bird A.C., Bhattacharya S.S. Am. J. Hum. Genet. 62:1248-1252(1998) [PubMed: 9545390] [Abstract] Cited for: VARIANTS CYS-141; GLN-415; ASP-523 AND SER-659. |
| [7] | "No mutations in the coding region of the PRKCG gene in three families with retinitis pigmentosa linked to the RP11 locus on chromosome 19q." Dryja T.P., McEvoy J., McGee T.L., Berson E.L. Am. J. Hum. Genet. 65:926-928(1999) [PubMed: 10441600] [Abstract] Cited for: SHOWS THAT THE VARIANTS ARE NOT A CAUSE OF RP11. |
| [8] | "Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia." Chen D.-H., Brkanac Z., Verlinde C.L.M.J., Tan X.-J., Bylenok L., Nochlin D., Matsushita M., Lipe H., Wolff J., Fernandez M., Cimino P.J., Bird T.D., Raskind W.H. Am. J. Hum. Genet. 72:839-849(2003) [PubMed: 12644968] [Abstract] Cited for: VARIANTS SCA14 TYR-101; PRO-119 AND ASP-128. |
| [9] | "The C2 domain of PKCdelta is a phosphotyrosine binding domain." Benes C.H., Wu N., Elia A.E.H., Dharia T., Cantley L.C., Soltoff S.P. Cell 121:271-280(2005) [PubMed: 15851033] [Abstract] Cited for: INTERACTION WITH CDCP1. |
| + | Additional computationally mapped references. |
Web resources
| Mutations of the PRKCG gene Retina International's Scientific Newsletter |
| GeneReviews |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AF345987 mRNA. Translation: AAK13533.1. BC047876 mRNA. Translation: AAH47876.1. M13977 mRNA. Translation: AAA60102.1. Different termination. Z15114 mRNA. Translation: CAA78820.1. | |||||||||||||||||||
| PIR | D24664. | ||||||||||||||||||
| RefSeq | NP_002730.1. | ||||||||||||||||||
| UniGene | Hs.631564 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| SMR | P05129. Positions 93-158, 348-683. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P05129. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P05129. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PeptideAtlas | P05129. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000126583. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 5582. | ||||||||||||||||||
| KEGG | hsa:5582. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| H-InvDB | HIX0027463. | ||||||||||||||||||
| HGNC | HGNC:9402. PRKCG. | ||||||||||||||||||
| HPA | CAB013051. | ||||||||||||||||||
| MIM | 176980. gene. 605361. phenotype. | ||||||||||||||||||
| Orphanet | 99. Cerebellar ataxia, autosomal dominant. | ||||||||||||||||||
| PharmGKB | PA33766. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOGENOM | P05129. | ||||||||||||||||||
| HOVERGEN | P05129. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P05129. | ||||||||||||||||||
| CleanEx | HS_PRKCG. | ||||||||||||||||||
| GermOnline | ENSG00000126583. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR000008. C2_Ca-dep. IPR002219. DAG_PE_bd. IPR015745. PKC. IPR000961. Pkinase_C. IPR014375. Prot_kin_PKC_alpha. IPR000719. Prot_kinase_core. IPR017441. Protein_kinase_ATP_bd_CS. IPR017442. Se/Thr_pkinase-rel. IPR008271. Ser_thr_pkin_AS. IPR002290. Ser_thr_pkinase. [Graphical view] | ||||||||||||||||||
| PANTHER | PTHR22985:SF86. PKC. 1 hit. | ||||||||||||||||||
| Pfam | PF00130. C1_1. 2 hits. PF00168. C2. 1 hit. PF00069. Pkinase. 1 hit. PF00433. Pkinase_C. 1 hit. [Graphical view] | ||||||||||||||||||
| PIRSF | PIRSF000550. PKC_alpha. 1 hit. | ||||||||||||||||||
| PRINTS | PR00360. C2DOMAIN. PR00008. DAGPEDOMAIN. | ||||||||||||||||||
| ProDom | PD000001. Prot_kinase. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||
| SMART | SM00109. C1. 2 hits. SM00239. C2. 1 hit. SM00133. S_TK_X. 1 hit. SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS51285. AGC_KINASE_CTER. 1 hit. PS50004. C2. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. PS00479. ZF_DAG_PE_1. 2 hits. PS50081. ZF_DAG_PE_2. 2 hits. [Graphical view] | ||||||||||||||||||
| BLOCKS | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Entry information
| Entry name | KPCG_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P05129 | ||||||||
| Entry history |
| ||||||||

Clusters with